Gilead Earnings, Revenue Beat in Q2
2022.08.02 23:10
Gilead Earnings, Revenue Beat in Q2
Investing.com – Gilead (NASDAQ:GILD) reported on Tuesday second quarter earnings that beat analysts’ forecasts and revenue that topped expectations.
Gilead announced earnings per share of $1.58 on revenue of $6.26B. Analysts polled by Investing.com anticipated EPS of $1.52 on revenue of $5.86B.
Gilead shares are down 18% from the beginning of the year, still down 19.67% from its 52 week high of $74.12 set on December 30, 2021. They are under-performing the S&P 500 which is down 14.14% from the start of the year.
Gilead shares lost 1.49% in after-hours trade following the report.
Gilead follows other major Healthcare sector earnings this month
Gilead’s report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
